Jefferies Financial Group’s BeOne Medicines ONC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$512K Buy
18,200
+11,800
+184% +$4.04M ﹤0.01% 971
2026
Q2
$1.82M Buy
6,400
+200
+3% +$58.9K 0.01% 726
2026
Q1
$1.84M Hold
6,200
– – 0.01% 671
2025
Q4
$1.88M Buy
+6,200
New +$2.03M 0.01% 839
2025
Q3
– Sell
-2,900
Closed -$702K – 1740
2025
Q2
$702K Hold
2,900
– – 0.01% 818
2025
Q1
$789K Buy
2,900
+900
+45% +$210K 0.01% 896
2024
Q4
$369K Buy
+2,000
New +$409K ﹤0.01% 1197
2024
Q2
– Sell
-8,043
Closed -$1.26M – 1945
2024
Q1
$1.26M Sell
8,043
-37,957
-83% -$6.11M 0.01% 739
2023
Q4
$8.3M Hold
46,000
– – 0.05% 268
2023
Q3
$8.27M Buy
+46,000
New +$9.1M 0.07% 208

Other funds holding ONC

Jefferies Financial Group's ONC Position: Q3 2026 in Review

Jefferies Financial Group increased its BeOne Medicines (ONC) stake by 184% in Q3 2026, buying an estimated $4.04M and bringing the position to 18,200 shares worth $512K. The position accounts for ﹤0.01% of the portfolio, ranked #971.

Jefferies Financial Group first reported a position in ONC in Q3 2023 and has held it in 10 quarters since. The position peaked at $8.3M in Q4 2023. 323 funds tracked by Wall St. Rank hold ONC as of Q3 2026.

  • Jefferies Financial Group held 18,200 shares of BeOne Medicines worth $512K as of Q3 2026.
  • Jefferies Financial Group bought 11,800 BeOne Medicines shares in Q3 2026, an estimated $4.04M.
  • BeOne Medicines made up ﹤0.01% of Jefferies Financial Group's portfolio in Q3 2026, its #971 holding.
  • Jefferies Financial Group first reported a position in BeOne Medicines in Q3 2023 and has held it in 10 quarters since.
  • Jefferies Financial Group's BeOne Medicines position peaked at $8.3M in Q4 2023.
  • 323 funds tracked by Wall St. Rank held BeOne Medicines as of Q3 2026.

Based on Jefferies Financial Group's 13F filing for Q3 2026, filed 5 Nov 2026.